An Observational Study of Avastin (Bevacizumab) in First Line in Patients With Metastatic Colorectal Cancer (AVANiS)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
This observational study will evaluate the use in clinical practice and the efficacy of Avastin (bevacizumab) in patients with metastatic colorectal cancer who have not received prior chemotherapy treatment in the metastatic setting. Patients for whom the treating physician has decided to initiate therapy with Avastin will be followed for 10 months.
Epistemonikos ID: c9010be52d4a8bca601029e36e30bf2495431e27
First added on: May 11, 2024